Research Output per year
Fingerprint Dive into the research topics where Willem H. van Harten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 95 Similar Profiles
Cost-Benefit Analysis
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Costs and Cost Analysis
Medicine & Life Sciences
Exercise
Medicine & Life Sciences
Biomedical Technology Assessment
Medicine & Life Sciences
Netherlands
Medicine & Life Sciences
Survivors
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1994 2019
Adherence to and satisfaction with low-intensity physical activity and supervised moderate-high intensity exercise during chemotherapy for breast cancer
van Waart, H., Buffart, L. M., Stuiver, M. M., van Harten, W. H., Sonke, G. S. & Aaronson, N. K., 8 Aug 2019, In : Supportive care in cancer.Research output: Contribution to journal › Article › Academic › peer-review
Exercise
Breast Neoplasms
Drug Therapy
Patient Satisfaction
Self Report
1
Citation
(Scopus)
Cost effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer on the basis of a randomized phase III trial
Koole, S. N., Van Lieshout, C., Van Driel, W. J., Van Schagen, E., Sikorska, K., Kieffer, J. M., Schagen van Leeuwen, J. H., Schreuder, H. W. R., Hermans, R. H., De Hingh, I. H., Van Der Velden, J., Arts, H. J., Massuger, L. F. A. G., Aalbers, A. G., Verwaal, V. J., Van De Vijver, K. K., Aaronson, N. K., Van Tinteren, H., Sonke, G. S., Van Harten, W. H. & 1 others, 10 Aug 2019, In : Journal of clinical oncology. 37, 23, p. 2041-2050 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Ovarian Neoplasms
Cost-Benefit Analysis
Quality-Adjusted Life Years
Drug Therapy
Costs and Cost Analysis
3
Citations
(Scopus)
14
Downloads
(Pure)
Impact of organ-on-a-chip technology on pharmaceutical R&D costs
Franzen, N., van Harten, W. H., Retèl, V. P., Loskill, P., van den Eijnden-van Raaij, J. & IJzerman, M., 1 Sep 2019, In : Drug discovery today. 24, 9, p. 1720-1724 5 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access
File
Pharmaceutical Technology
Costs and Cost Analysis
Technology
Drug Costs
Drug Discovery
Implementing physical activity programs for patients with cancer in current practice: patients’ experienced barriers and facilitators
IJsbrandy, C., Hermens, R. P. M. G., Boerboom, L. W. M., Gerritsen, W. R., van Harten, W. H. & Ottevanger, P. B., 25 Dec 2019, In : Journal of cancer survivorship.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
File
Exercise
Neoplasms
Organizations
Delivery of Health Care
Survivors
Improving workflow control in radiotherapy using discrete-event simulation
Vieira, B., Demirtas, D., Van De Kamer, J. B., Hans, E. W. & Van Harten, W., 24 Oct 2019, In : BMC medical informatics and decision making. 19, 199, 13 p., 199.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
Workflow
Radiotherapy
Referral and Consultation
Appointments and Schedules
Therapeutics
Activities 2015 2015
- 1 Oral presentation
Alliantie Regionale Topzorg
Willem H. van Harten (Speaker)4 Mar 2015
Activity: Talk or presentation › Oral presentation